Benzinga | Aug 5, 2021 05:23PM EDT

Harpoon Therapeutics Q2 EPS $(0.52) Down From $(0.51) YoY, Sales $5.84M Up From $2.76M YoY

Harpoon Therapeutics (NASDAQ:HARP) reported quarterly losses of $(0.52) per share. This is a 1.96 percent decrease over losses of $(0.51) per share from the same period last year. The company reported $5.84 million in sales this quarter. This is a 111.37 percent increase over sales of $2.76 million the same period last year.